Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roberta Semprini
Observed names:
R Semprini,
R. Semprini,
SemprinI, Roberta,
Semprini, Roberta
Observed institutions:
University of Rome Tor Vergata,
Policlinico Tor Vergata,
Fondazione Santa Lucia,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS San Raffaele Roma,
Sovereign Military Order of Malta,
Sapienza University of Rome
show all 7
OpenAlex ID:
A5041266038
Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?
1998
·
A Peppe
, P Stanzione
, et al.
·
Electroencephalography and Clinical Neurophysiology
·
59
Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals
2014
·
Alessandro Martorana
, Francesco Di Lorenzo
, et al.
·
Frontiers in Aging Neuroscience
·
53
PDF
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy
1998
·
P Stanzione
, R Semprini
, et al.
·
Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section
·
39
An electrophysiological study of D2 dopaminergic actions in normal human retina: A tool in Parkinson's disease
1992
·
Paolo Stanzione
, Raimondo Traversa
, et al.
·
Neuroscience Letters
·
28
Quantitative EEG changes in non‐demented Parkinson's disease patients before and during L‐dopa therapy
1996
·
P. Stanzione
, M.G. Marciani
, et al.
·
European Journal of Neurology
·
26
Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram
1995
·
P. Stanzione
, M. Pierantozzi
, et al.
·
Vision Research
·
22
PDF
Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype
2021
·
Caterina Motta
, Martina Assogna
, et al.
·
European Journal of Neurology
·
16
Apathy as Marker of Frail Status
2012
·
Roberta Semprini
, Adele Lubrano
, et al.
·
Journal of Aging Research
·
15
PDF
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations
1999
·
P Stanzione
, I Bodis-Wollner
, et al.
·
Clinical Neurophysiology
·
14
Gait impairment in neurological disorders: a new technological approach.
2009
·
Roberta Semprini
, Patrizio Sale
, et al.
·
PubMed
·
13
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status
1997
·
P. Stanzione
, R. Traversa
, et al.
·
European Journal of Neurology
·
13
Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with diabetes type 1 and type 2
2018
·
Roberta Semprini
, Alessandro Martorana
, et al.
·
Minerva Medica
·
9
A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of 1-dopa, 1-deprenyl and dopaminoagonists. Study design and short term results
1992
·
The Italian Parkinson Study Group
, T. Caraceni
, et al.
·
The Italian Journal of Neurological Sciences
·
9
Kyphoplasty
2004
·
Salvatore Masala
, Domenicantonio Tropepi
, et al.
·
American Journal of Physical Medicine & Rehabilitation
·
7
N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
1995
·
R Traversa
, M Pierantozzi
, et al.
·
PubMed
·
7
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
2020
·
Mauro Ragonese
, Monica Larosa
, et al.
·
Diabetes Therapy
·
5
PDF
Insulin and the Future Treatment of Alzheimer's Disease
2016
·
Roberta Semprini
, Giacomo Koch
, et al.
·
CNS & Neurological Disorders - Drug Targets
·
5
Ageing as a Trait de Union Between Diabetes and Dementia for Frailty
2013
·
Roberta Semprini
, Mauro Ragonese
, et al.
·
CNS & Neurological Disorders - Drug Targets
·
4
Clinical Profile of Alzheimer’s Disease Non-Responder Patient
2011
·
Alessandro Martorana
, Roberta Semprini
, et al.
·
InTech eBooks
·
3
PDF
N30 wave of somatosensory evoked potentials in Parkinson's disease: a pharmacological approach.
1996
·
R Traversa
, M Pierantozzi
, et al.
·
PubMed
·
2
N30 amplitude reduction in Parkinson's disease: a pathophysiologic study by means of pharmacological tools
1995
·
R. Traversa
, M. Pierantozzi
, et al.
·
Electroencephalography and Clinical Neurophysiology
·
1
Pattern PERG in Parkinson's disease patients and in post-traumatic parkinsonian patients confirms retinal dopaminergic deficit in Parkinson's disease
1995
·
A. Peppe
, R. Traversa
, et al.
·
Electroencephalography and Clinical Neurophysiology
SEP N30 wave modification during sleep related to muscular tone variations
1995
·
R. Traversa
, G.L. Gigli
, et al.
·
Electroencephalography and Clinical Neurophysiology
Show more works
View as search
Works count:
28
Citation count:
350
H-index:
11
I10-index:
11
Year
Topic
Type